AtriCure
ATRC
113 hedge funds and large institutions have $431M invested in AtriCure in 2016 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 47 increasing their positions, 38 reducing their positions, and 14 closing their positions.
49% more call options, than puts
Call options by funds: $103K | Put options by funds: $69K
24% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 38
4% less funds holding
Funds holding: 118 → 113 (-5)
28% less capital invested
Capital invested by funds: $599M → $431M (-$169M)
36% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 14
67% less funds holding in top 10
Funds holding in top 10: 6 → 2 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$31.3M |
| 2 |
Millennium Management
New York
|
+$14.4M |
| 3 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
+$2.35M |
| 4 |
Renaissance Technologies
New York
|
+$2.02M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.68M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
-$18M |
| 2 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
-$11.1M |
| 3 |
RIM
RS Investment Management
San Francisco,
California
|
-$8.72M |
| 4 |
CM
Castleark Management
Chicago,
Illinois
|
-$7.21M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$5.26M |
ATRC Hedge Fund Activity: Q1 2016 in Review
113 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q1 2016, worth a combined $431M — down 28% from $599M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of ATRC and 9 opened new positions — a net loss of 5 holders — while 38 trimmed existing stakes and 47 added.
The largest buyer was Fidelity Investments, adding an estimated $31.3M. The largest seller was Broadfin Capital, exiting entirely with an estimated $18M sold.
- 113 institutional investors held AtriCure (ATRC) as of Q1 2016, down from 118 in Q4 2015.
- Funds reported $431M of AtriCure stock for Q1 2016, down 28% quarter-over-quarter.
- 9 funds opened new AtriCure positions in Q1 2016 and 14 closed out, a net change of -5 holders.
- The largest AtriCure buyer in Q1 2016 was Fidelity Investments, an estimated $31.3M added.
- The largest AtriCure seller in Q1 2016 was Broadfin Capital, an estimated $18M sold.
Based on aggregated 13F filings for Q1 2016.